First-Line Antibiotics for Suspected Cellulitis
For nonpurulent cellulitis (the most common presentation), start with a beta-lactam antibiotic targeting beta-hemolytic streptococci—specifically cephalexin 500 mg four times daily or dicloxacillin 500 mg four times daily for 5-10 days. 1
Clinical Decision Algorithm
Step 1: Classify the Cellulitis Type
Nonpurulent cellulitis (no drainage, no exudate, no abscess):
First-line: Beta-lactam antibiotics targeting streptococci 1, 2
Duration: 5-10 days based on clinical response 1
Purulent cellulitis (drainage or exudate present, no drainable abscess):
- First-line: Cover CA-MRSA empirically 1
Step 2: Assess for Treatment Failure Indicators
Add MRSA coverage if:
- No response to beta-lactam therapy after 48-72 hours 1, 2
- Systemic toxicity present (fever, tachycardia, hypotension) 1
- Severe infection requiring hospitalization 1
Step 3: Hospitalized/Complicated Cases
For hospitalized patients with complicated SSTI (deeper infections, major wounds, systemic illness):
- IV vancomycin 30 mg/kg/day in 2 divided doses (first choice) 1, 2
- Linezolid 600 mg IV/PO twice daily (alternative) 1
- Daptomycin 4 mg/kg IV once daily (alternative) 1
- Duration: 7-14 days based on response 1
Key Evidence and Rationale
The IDSA guidelines 1, 2 consistently emphasize that nonpurulent cellulitis is primarily caused by beta-hemolytic streptococci, NOT MRSA. This is critical because many clinicians over-treat with MRSA coverage unnecessarily. The guidelines explicitly state that "empirical therapy for infection due to β-hemolytic streptococci is recommended" and that "the role of CA-MRSA is unknown" in nonpurulent cellulitis 1.
Clindamycin receives the highest evidence grade (A-I) among oral options when MRSA coverage is needed 1, making it the preferred single agent when dual coverage is desired since it covers both streptococci and MRSA 1.
Critical Pitfalls to Avoid
Don't automatically cover MRSA for simple nonpurulent cellulitis - This is the most common error. Reserve MRSA coverage for purulent infections or treatment failures 1, 5.
Bilateral cellulitis is rare - Consider alternative diagnoses like venous stasis dermatitis, which doesn't require antibiotics 6, 5.
Check local clindamycin resistance rates - If erythromycin resistance exceeds 10%, clindamycin may have inducible resistance and should be avoided 1.
Don't use TMP-SMX alone for nonpurulent cellulitis - It lacks adequate streptococcal coverage and must be combined with a beta-lactam 1.
Avoid rifampin - It should not be used as monotherapy or adjunctive therapy for cellulitis 1.
Special Populations
Children:
- Same antibiotics at weight-based dosing: cephalexin 25-50 mg/kg/day in 3-4 divided doses 3, 4
- Avoid tetracyclines under age 8 1, 2, 1
- For hospitalized children with complicated SSTI: vancomycin 40 mg/kg/day in 4 divided doses 1
Pregnancy:
- Beta-lactams (cephalexin, amoxicillin) are safe
- Avoid TMP-SMX in third trimester 1